Status: Recruiting
Rademikibart Add-on Treatment of an Acute COPD Exacerbation (Seabreeze STAT COPD)
This is a Phase 2, multicenter study in adult participants with an acute COPD exacerbation and type 2 inflammation
Participants needed: 160
Trial details
Phase: Phase 2Age: 40-80Biological sex: AllType: InterventionalSponsor: Connect Biopharm LLCUpdated: Jun 12, 2026Locations: 53
Eligibility criteria
Physician-diagnosed COPD with duration of ≥12 months. [+6]
Regular use of immunosuppressive medication 12 weeks or 5 half-lives prior to ra... [+17]